Inactivation of LARS2, located at the commonly deleted region 3p21.3, by both epigenetic and genetic mechanisms in nasopharyngeal carcinoma

Acta Biochimica et Biophysica Sinica

Volumn 41, Issue 1, 2009, Pages 54-62

  Zhou, Wen ^a   Feng, Xiangling ^a   Li, Hong ^a   Wang, Lei ^a   Zhu, Bin ^a   Liu, Weidong ^a   Zhao, Ming ^a   Yao, Kaitai ^a,b   Ren, Caiping ^a  

^a Central South University   (China)

^b SOUTHERN MEDICAL UNIVERSITY   (China)

Author keywords

Homozygous deletion (HD); LARS2; Methylation; Mutation; Nasopharyngeal carcinoma

Indexed keywords

DNA; LEUCINE TRANSFER RNA LIGASE; MESSENGER RNA; PRIMER DNA;

ALLELE; ARTICLE; CHROMOSOME 3; DNA METHYLATION; DRUG ANTAGONISM; GENE DELETION; GENE SILENCING; GENETIC EPIGENESIS; GENETICS; HUMAN; MUTATION; NASOPHARYNX TUMOR; NUCLEOTIDE SEQUENCE; PROMOTER REGION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SINGLE STRAND CONFORMATION POLYMORPHISM;

ALLELES; BASE SEQUENCE; CHROMOSOMES, HUMAN, PAIR 3; DNA; DNA METHYLATION; DNA PRIMERS; EPIGENESIS, GENETIC; GENE SILENCING; HUMANS; LEUCINE-TRNA LIGASE; MUTATION; NASOPHARYNGEAL NEOPLASMS; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL; PROMOTER REGIONS, GENETIC; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SEQUENCE DELETION;

EID: 64049100419     PISSN: 16729145     EISSN: 17457270     Source Type: Journal    
DOI: 10.1093/abbs/gmn006     Document Type: Article

References (33)

1. Tao Q and Chan AT. Nasopharyngeal carcinoma: molecular pathogenesis and therapeutic developments. Expert Rev Mol Med 2007, 9: 1-24
2. Wei WI and Sham JS. Nasopharyngeal carcinoma. Lancet 2005, 365: 2041-2054
3. Lo KW, To KF and Huang DP. Focus on nasopharyngeal carcinoma. Cancer Cell 2004, 5: 423-428
4. Huang Z, Desper R, Schaffer AA, Yin Z, Li X and Yao K. Construction of tree models for pathogenesis of nasopharyngeal carcinoma. Genes Chromosomes Cancer 2004, 40: 307-315
5. Yan W, Song L, Wei W, Li A, Liu J and Fang Y. Chromosomal abnormalities associated with neck nodal metastasis in nasopharyngeal carcinoma. Tumour Biol 2005, 26: 306-312
6. Chen YJ, Ko JY, Chen PJ, Shu CH, Hsu MT, Tsai SF and Lin CH. Chromosomal aberrations in nasopharyngeal carcinoma analyzed by comparative genomic hybridization. Genes Chromosomes Cancer 1999, 25: 169-175
7. Fang Y, Guan X, Guo Y, Sham J, Deng M, Liang Q and Li H, et al. Analysis of genetic alterations in primary nasopharyngeal carcinoma by comparative genomic hybridization. Genes Chromosomes Cancer 2001, 30: 254-260
8. Hui AB, Or YY, Takano H, Tsang RK, To KF, Guan XY and Sham JS, et al. Array-based comparative genomic hybridization analysis identified cyclin D1 as a target oncogene at 11q13.3 in nasopharyngeal carcinoma. Cancer Res 2005, 65: 8125-8133
9. Chan AS, To KF, Lo KW, Mak KF, Pak E, Chiu B and Tse GM, et al. High frequency of chromosome 3p deletion in histologically normal nasopharyngeal epithelia from southern Chinese. Cancer Res 2000, 60: 5365-5370
10. Zhou L, Jiang W, Ren C, Yin Z, Feng X, Liu W and Tao Q, et al. Frequent hypermethylation of RASSF1A and TSLC1, and high viral load of Epstein-Barr virus DNA in nasopharyngeal carcinoma and matched tumor-adjacent tissues. Neoplasia 2005, 7: 809-815
11. Yi HM, Ren CP, Peng D, Zhou L, Li H and Yao KT. Expression, loss of heterozygosity, and methylation of GNAT1 gene in nasopharyngeal carcinoma. Ai Zheng 2007, 26: 9-14
12. Yi HM, Li H, Peng D, Zhang HJ, Wang L, Zhao M and Yao KT, et al. Genetic and epigenetic alterations of LTF at 3p21.3 in nasopharyngeal carcinoma. Oncol Res 2006, 16: 261-272
13. Qiu GH, Tan LK, Loh KS, Lim CY, Srivastava G, Tsai ST and Tsao SW, et al. The candidate tumor suppressor gene BLU, located at the commonly deleted region 3p21.3, is an E2F-regulated, stress-responsive gene and inactivated by both epigenetic and genetic mechanisms in nasopharyngeal carcinoma. Oncogene 2004, 23: 4793-4806
14. Kiss H, Kedra D, Yang Y, Kost-Alimova M, Kiss C, O'Brien KP and Fransson I, et al. A novel gene containing LIM domains (LIMD1) is located within the common eliminated region 1 (C3CER1) in 3p21.3. Hum Genet 1999, 105: 552-559
15. Sambrool J, Fritsch EF and Maniatis T. Molecular Cloning: A Laboratory Manual, 2nd ed. NY: Cold Spring Harbor Laboratory Press, 1989
16. Senchenko VN, Liu J, Loginov W, Bazov I, Angeloni D, Seryogin Y and Ermilova V, et al. Discovery of frequent homozygous deletions in chromosome 3p21.3 LUCA and AP20 regions in renal, lung and breast carcinomas. Oncogene 2004, 23: 5719-5728
17. Peng D, Ren CP, Yi HM, Zhou L, Yang XY, Li H and Yao KT, et al. Genetic and epigenetic alterations of DLC-1, a candidate tumor suppressor gene, in nasopharyngeal carcinoma. Acta Biochim Biophys Sin 2006, 38: 349-355
18. Zhou L, Feng XL, Shan WJ, Zhou W, Liu W, Wang L and Zhu B, et al. Epigenetic and genetic alterations of the EDNRB gene in nasopharyngeal carcinoma. Oncology 2007, 72: 357-363
19. Tuhkanen H, Anttila M, Kosma VM, Ylä-Herttuala S, Heinonen S, Kuronen A and Juhola M, et al. Genetic alterations in the peritumoral stromal cells of malignant and borderline epithelial ovarian tumors as indicated by allelic imbalance on chromosome 3p. Int J Cancer 2004, 109: 247-252
20. Hesson LB, Cooper WN and Latif F. Evaluation of the 3p21.3 tumoursuppressor gene cluster. Oncogene 2007, 26: 7283-7301
21. Protopopov A, Kashuba V, Zabarovska VI, Muravenko OV, Lerman MI, Klein G and Zabarovsky ER. An integrated physical and gene map of the 3.5-Mb chromosome 3p21.3 (AP20) region implicated in major human epithelial malignancies. Cancer Res 2003, 63: 404-412
22. Kok K, Naylor SL and Buys CH. Deletions of the short arm of chromosome 3 in solid tumors and the search for suppressor genes. Adv Cancer Res 1997, 71: 27-92
23. Kwong J, Chow LS, Wong AY, Hung WK, Chung GT, To KF and Chan FL, et al. Epigenetic inactivation of the deleted in lung and esophageal cancer 1 gene in nasopharyngeal carcinoma. Genes Chromosomes Cancer 2007, 46: 171-180
24. Hart LM, Hansen T, Rietveld I, Dekker JM, Nijpels G, Janssen GM and Arp PA, et al. Evidence that the mitochondrial leucyl tRNA synthetase (LARS2) gene represents a novel type 2 diabetes susceptibility gene. Diabetes 2005, 54: 1892-1895
25. Munakata K, Iwamoto K, Bundo M and Kato T. Mitochondrial DNA 3243A > mutation and increased expression of LARS2 gene in the brains of patients with bipolar disorder and schizophrenia. Biol Psychiatry 2005, 57: 525-532
26. Zabarovsky ER, Lerman MI and Minna JD. Tumor suppressor genes on chromosome 3p involved in the pathogenesis of lung and other cancers. Oncogene 2002, 21: 6915-6935
27. Angeloni D. Molecular analysis of deletions in human chromosome 3p21 and the role of resident cancer genes in disease. Brief Funct Genomic Proteomic 2007, 6: 19-39
28. Stoehr R, Wissmann C, Suzuki H, Knuechel R, Krieg RC, Klopocki E and Dahl E, et al. Deletions of chromosome 8p and loss of sFRP1 expression are progression markers of papillary bladder cancer. Lab Invest 2004, 84: 465-478
29. Yang HW, Chen YZ, Piao HY, Takita J, Soeda E and Hayashi Y. DNA fragmentation factor 45 (DFF45) gene at 1p36.2 is homozygously deleted and encodes variant transcripts in neuroblastoma cell line. Neoplasia 2001, 3: 165-169
30. Kwong J, Lo KW, To KF, Teo PM, Johnson PJ and Huang DP. Promoter hypermethylation of multiple genes in nasopharyngeal carcinoma. Clin Cancer Res 2002, 8: 131-137
31. Modica-Napolitano JS, Kulawiec M and Singh KK. Mitochondria and human cancer. Curr Mol Med 2007; 7: 121-131
32. Jerónimo C, Nomoto S, Caballero OL, Usadel H, Henrique R, Varzim G and Oliveira J, et al. Mitochondrial mutations in early stage prostate cancer and bodily fluids. Oncogene 2001, 20: 5195-5198
33. Hiyama T, Tanaka S, Shima H, Kose K, Tuncel H, Ito M and Kitadai Y, et al. Somatic mutation in mitochondrial DNA and nuclear microsatellite instability in gastric cancer. Oncol Rep 2003, 10:1837-1841